A 60-Year-Old Man With Progressive Anemia While Receiving Checkpoint Blockade Therapy for Relapsed Myelofibrosis.
Oncology (Williston Park)
; 31(2): 122-4, 126-8, 2017 02 15.
Article
in En
| MEDLINE
| ID: mdl-28205192
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Primary Myelofibrosis
/
Ipilimumab
/
Antineoplastic Agents, Immunological
/
Anemia
Type of study:
Etiology_studies
Limits:
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Oncology (Williston Park)
Journal subject:
NEOPLASIAS
Year:
2017
Document type:
Article